FDA, Cymbalta
Lilly's weight loss drug shortage deemed over
A class II risk level is given to products that "may cause temporary or medically reversible adverse health consequences." ...
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries.
The U.S. Food and Drug Administration has approved Avadel Pharmaceuticals' sleep disorder drug for children aged 7 years and ...
This could be due to U.S. Food and Drug Administration recalls. The FDA has continued to suspend food and drug items that people might typically buy. Here is a list of September food ...
On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral medication that is manufactured by Bristol Myers Squibb in New Jersey.
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
Amid an ongoing pet food recall, the U.S. Food and Drug Administration (FDA) is urging pet owners not to give their ...
Passengers on 200 Delta flights were denied in-flight meal service after food safety issues were discovered in the airline's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback